• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Integrum

8.18 SEK

-0.49 %

Less than 1K followers

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.49 %
+5.68 %
+17.36 %
-21.35 %
-23.98 %
-58.24 %
-52.77 %
-88.73 %
-58.95 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Read more
Market cap
218.14M SEK
Turnover
56.38K SEK
Revenue
91.39M
EBIT %
-58.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
3.9
2026

Interim report Q1'27

3.12
2026

Interim report Q2'27

4.3
2027

Interim report Q3'27

Regulatory press release29.06.2026, 08.30

Ukraine's Ministry of Health submits proposal to the government on expanded use of osseointegration in healthcare

Integrum
Regulatory press release16.06.2026, 15.23

Integrum receives customs duty refund of approximately SEK 2.6 million

Integrum
Regulatory press release09.06.2026, 09.15

Integrum intends to incorporate all operations within bionics under the name Afyri

Integrum

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release04.06.2026, 07.15

YEAR-END REPORT 2025/2026

Integrum
Regulatory press release01.06.2026, 13.35

Integrum invites to presentation of Q4 2025/26 results

Integrum
Press release05.05.2026, 15.56

Correction: Integrum launches patient-facing website in the US to increase patient flow and awareness of OPRA Implant System

Integrum
Press release05.05.2026, 15.38

Integrum launches patient-facing website in the US to increase patient flow and awareness of OPRA Implant System

Integrum
Regulatory press release30.04.2026, 07.56

Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items

Integrum
Press release15.04.2026, 16.36

Integrum AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare

Integrum
Regulatory press release05.03.2026, 07.45

Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26

Integrum
Press release03.03.2026, 18.02

Integrum AB: Integrum invites to presentation of Q3 2025/26 results

Integrum
Press release20.02.2026, 09.01

DNB Carnegie Access: Integrum: Discontinuing coverage

Integrum
Regulatory press release11.02.2026, 15.40

Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System

Integrum
Regulatory press release02.12.2025, 21.27

Integrum AB: Integrum's rights issue oversubscribed

Integrum
Regulatory press release21.11.2025, 07.00

Integrum AB: Integrum publishes Interim Report for Q2 2025/26

Integrum
Press release19.11.2025, 16.01

Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation

Integrum
Press release18.11.2025, 16.12

Integrum AB: The subscription period in Integrum's rights issue has begun

Integrum
Regulatory press release14.11.2025, 08.00

Integrum AB: Integrum publishes information document regarding rights issue

Integrum
Regulatory press release13.11.2025, 17.56

Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26

Integrum
Regulatory press release10.11.2025, 16.55

Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs

Integrum